Submit a Release
Home
All
ESG
Health
Technology
Finance
Contributors
Sub Menu
Submit a Release
main-search-pop
Main menu
Health
Results: 313-324 of 8667
Johnson & Johnson Announces CE Mark Approval for the New ETHICON™ 4000 Stapler
4Moving Biotech Granted FDA Fast Track Designation to 4P004, Supporting an Accelerated Development Pathway in Knee Osteoarthritis
Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA
Jazz Pharmaceuticals to Report First Quarter Financial Results on May 5, 2026
Alkermes to Report First Quarter Financial Results on May 5, 2026
SBC Medical Announces Closing of Previously Announced Secondary Public Offering of 3.1 million shares of Common Stock
Incyte Highlights New Phase 3 Tafasitamab Data at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting
Suvoda introduces agentic RTSM, cutting clinical trial start-up timelines by up to 80%
Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic
Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology
Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
Minaris Delivers 100% Manufacturing and Release Success for Chimeric Therapeutics' CDH17 Autologous CAR‑T Program
Prev
Page
1
2
…
26
27
28
…
722
723
Next
Page
